MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572 | -67.3% | 13,139 | -72.8% | 0.00% | -63.6% |
| Q2 2023 | $1,747 | -50.5% | 48,353 | -49.1% | 0.01% | -56.0% |
| Q1 2023 | $3,529 | -18.4% | 94,912 | -0.6% | 0.02% | -24.2% |
| Q4 2022 | $4,327 | -99.9% | 95,495 | -0.0% | 0.03% | -35.3% |
| Q3 2022 | $6,672,000 | +81.2% | 95,535 | +74.2% | 0.05% | +88.9% |
| Q2 2022 | $3,682,000 | -18.3% | 54,842 | 0.0% | 0.03% | +3.8% |
| Q1 2022 | $4,509,000 | -44.6% | 54,842 | -0.0% | 0.03% | -38.1% |
| Q4 2021 | $8,133,000 | -15.7% | 54,869 | +0.6% | 0.04% | -20.8% |
| Q3 2021 | $9,648,000 | -11.7% | 54,535 | -19.4% | 0.05% | -20.9% |
| Q2 2021 | $10,925,000 | +619.7% | 67,633 | +663.4% | 0.07% | +570.0% |
| Q1 2021 | $1,518,000 | – | 8,859 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |